# ABACAVIR; LAMIVUDINE
> **NDA207369** · New Drug Application · Sponsor: HETERO LABS LTD V · Approved 2015-11-13
## Drug
- **FDA Application Number:** NDA207369
- **Application type:** New Drug Application
- **Brand name:** ABACAVIR; LAMIVUDINE
- **Generic name:** Abacavir
- **Active ingredients:** ABACAVIR; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HETERO LABS LTD V
- **First approval:** 2015-11-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207369)
---
*MORVS · CC0 1.0*